Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIMOSA: Morphine in Moderate OSA
NCT03127800Phase 3Terminated
- Start
- May 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of morphine in pain. Primary endpoint: Change in Apnoea-Hypopnea Index at 4 months. Started May 2016; status: terminated.
02
Drugs
morphine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03127800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03127800.